Search results for "Drug Safety"


 
Results 21 - 30 of about 31 for "Drug Safety".

New COPD treatment, warnings on insomnia and migraine drugs

It's also recommended that clinicians discontinue the drug in patients with symptoms of liver injury. ... A drug safety communication about the risk of name confusion between ado-trastuzumab emtansine (Kadcyla) and trastuzumab (Herceptin).
July 2013

Polypill gets approval, fenofibric acid gets label change

The drug's safety and efficacy were evaluated in a clinical trial with more than 14,000 patients, in which it showed similar ability to warfarin in preventing stroke. ... Given the conflicting nature of the existing research findings on this issue, the
January 2012

Safe prescribing can lessen overdose risk

Caleb Alexander, MD, co-director of the Johns Hopkins School of Public Health Center for Drug Safety and Effectiveness in Baltimore. ... educated about the risks and benefits and if you can effectively monitor for safety.
October 2016

Different patients, different doses

a drug safety expert and consultant in Chapel Hill, N.C. ... Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert Opin Drug Metab Toxicol.
May 2019

Trainees take charge at Leadership Day 2019

When meeting with Rep. Earl Blumenauer (D-OR), Ms. Blank and ACP Resident/Fellow Member Joel Burnett, MD, led discussions on prescription drug pricing and physician workforce issues. ... I don't have any problems with that,” although the downside is
July 2019

New drugs could improve anticoagulation rates

But at this point, he noted, the drug remains costly for many patients. ... Food and Drug Administration. FDA Drug Safety Communication: Safety review of post-market reports of serious bleeding events with the anticoagulant Pradaxa (dabigatran etexilate
April 2012

New drug treats cancer based on biomarker, not location

Photo by ThinkStock. A drug safety communication that canagliflozin (Invokana, Invokamet) causes an increased risk of leg and foot amputations. ... A drug safety communication about gadolinium-based contrast agents for MRI. An FDA review, initiated in
July 2017

Allergy may not be absolute obstacle to COVID-19 vaccine

Phillips, who is the John A. Oates Chair in Clinical Research and professor of medicine and pharmacology and of pathology, microbiology, and immunology at the Center for Drug Safety and Immunology
April 2021

Ranitidine pulled from market; COVID-19 updates

A drug safety communication regarding known side effects of hydroxychloroquine and chloroquine. ... The drug is contraindicated in patients with known allergy or hypersensitivity to rabbits or rabbit proteins.
June 2020

Pulmonary illnesses linked to e-cigarette products

A drug safety communication that hepatitis C medicines have led to rare cases of worsening liver function or liver failure in some patients. ... The drug was originally approved in 2014 to treat adults with idiopathic pulmonary fibrosis.
November 2019

Prev   1   2   3   Next